UK’s MHRA grants early access to Alnylam’s patisiran

UK’s MHRA adopts positive scientific opinion over hATTR amyloidosis drug patisiran. Image: Alnylam’s patisiran. Photo: courtesy of Adam Ciesielski/Freeimages.com.